Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Acute effects of walking, cycling, and yoga exercise on cognition in persons with relapsing-remitting multiple sclerosis without impaired cognitive processing speed.
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients.
Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Association between neuromyelitis optica and tuberculosis in a Chinese population.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Liposome-encapsulated peptides protect against experimental allergic encephalitis.
Multiple sclerosis and restless legs syndrome: a systematic review and meta-analysis.
Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
Functional Cognitive Disorder: A Common Cause of Subjective Cognitive Symptoms.
Incidence of Radiologically Isolated Syndrome: A Population-Based Study.
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Molecular mimicry as a mechanism for food immune reactivities and autoimmunity.
Information processing speed and attention in multiple sclerosis: Reconsidering the Attention Network Test (ANT).
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
Fumaric acid esters in psoriasis and multiple sclerosis.
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.

Pages